2022
DOI: 10.1080/02699052.2022.2106383
|View full text |Cite
|
Sign up to set email alerts
|

Concussion severity and functional outcome using biomarkers in children and youth involved in organized sports, recreational activities and non-sport related incidents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…They also appear to maintain statistically significant elevations for anywhere from 3 to 30 days following injury [ 148 , 149 ]. Some studies have suggested that acute concentrations of serum GFAP correlate with injury severity, in addition to cognitive performance and clinical outcomes at multiple time-points following concussion [ 150 , 151 , 152 , 153 ]. GFAP may be more relevant than other biomarkers for cases in which patients delay seeking care due to prolonged clearance from serum [ 148 ].…”
Section: Biochemical Concentrations In Blood and Other Tissuesmentioning
confidence: 99%
See 1 more Smart Citation
“…They also appear to maintain statistically significant elevations for anywhere from 3 to 30 days following injury [ 148 , 149 ]. Some studies have suggested that acute concentrations of serum GFAP correlate with injury severity, in addition to cognitive performance and clinical outcomes at multiple time-points following concussion [ 150 , 151 , 152 , 153 ]. GFAP may be more relevant than other biomarkers for cases in which patients delay seeking care due to prolonged clearance from serum [ 148 ].…”
Section: Biochemical Concentrations In Blood and Other Tissuesmentioning
confidence: 99%
“…Several studies have demonstrated that blood levels of UCH-L1 peak very early after head trauma and decrease rapidly, unlike GFAP, which tends to gradually rise over the first 24 h post-injury [ 148 , 153 ]. Day-of-injury measurements of UCH-L1 have demonstrated substantial prognostic value for predicting injury severity, the presence of CT lesions, and the quality of clinical outcomes [ 150 , 153 , 154 , 155 ]. In fact, the U.S. Food and Drug Administration has already approved, for clinical use, a blood test which measures circulating UCH-L1 and GFAP levels, to help determine the need for computed tomography (CT) scans within 12 h of head injury [ 156 ].…”
Section: Biochemical Concentrations In Blood and Other Tissuesmentioning
confidence: 99%